company background image
IVCR.Q logo

Invacare OTCPK:IVCR.Q Voorraadrapport

Laatste prijs

US$0.013

Marktkapitalisatie

US$512.8k

7D

-10.6%

1Y

-99.1%

Bijgewerkt

05 May, 2023

Gegevens

Financiële gegevens bedrijf

Invacare Corporation

OTCPK:IVCR.Q Voorraadrapport

Marktkapitalisatie: US$512.8k

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

IVCR.Q Overzicht aandelen

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide.

Over het bedrijf

IVCR.Q fundamentele analyse
Sneeuwvlok Score
Waardering2/6
Toekomstige groei0/6
Prestaties in het verleden0/6
Financiële gezondheid1/6
Dividenden0/6

Beloningen

Risicoanalyse

Earnings have declined by 2.6% per year over past 5 years
Does not have a meaningful market cap ($513K)
Highly volatile share price over the past 3 months
Has less than 1 year of cash runway

+ 1 meer risico

Invacare Corporation Concurrenten

Dynatronics

OTCPK:DYNT

US$790.3k

LogicMark

NasdaqCM:LGMK

US$858.3k

Electromedical Technologies

OTCPK:EMED

US$363.0k

Brain Scientific

OTCPK:BRSF

US$932.0k

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Invacare
Historische aandelenkoersen
Huidige aandelenkoersUS$0.013
52 Week HoogtepuntUS$1.64
52 Week LaagUS$0.011
Bèta0.51
11 maand verandering-10.00%
3 maanden verandering-62.60%
1 Jaar Verandering-99.09%
33 jaar verandering-99.77%
5 jaar verandering-99.92%
Verandering sinds IPO-99.49%

Recent nieuws en updates

Recent updates

Invacare falls on bankruptcy filing

Feb 01

Invacare announces additional draw of $5.5M term loans

Dec 27

Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates

Nov 14
Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates

Invacare GAAP EPS of -$0.92, revenue of $170.4M

Nov 07

Invacare receives non-compliance letter from NYSE

Sep 29

Invacare names Geoffrey Purtill as interim president and executive chief

Aug 29

Invacare adds two new directors after deal with largest investor Azurite

Aug 23

Returns Are Gaining Momentum At Invacare (NYSE:IVC)

Apr 30
Returns Are Gaining Momentum At Invacare (NYSE:IVC)

Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky

Jan 27
Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

Dec 01
Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load

Sep 30
Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load

When Should You Buy Invacare Corporation (NYSE:IVC)?

Aug 06
When Should You Buy Invacare Corporation (NYSE:IVC)?

Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

May 14
Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

Invacare EPS misses by $0.02, misses on revenue

May 05

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

May 03
Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

Invacare Corporation's (NYSE:IVC) Path To Profitability

Mar 03
Invacare Corporation's (NYSE:IVC) Path To Profitability

Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet

Feb 05
Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet

What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?

Jan 10
What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?

Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.

Dec 14
Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.

Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit

Nov 23
Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit

Invacare Corporation 2020 Q3 - Results - Earnings Call Presentation

Oct 30

Rendement voor aandeelhouders

IVCR.QUS Medical EquipmentUS Markt
7D-10.6%-0.6%-0.4%
1Y-99.1%22.6%34.1%

Rendement versus industrie: IVCR.Q underperformed the US Medical Equipment industry which returned -1.8% over the past year.

Rendement versus markt: IVCR.Q underperformed the US Market which returned 15.2% over the past year.

Prijsvolatiliteit

Is IVCR.Q's price volatile compared to industry and market?
IVCR.Q volatility
IVCR.Q Average Weekly Movement28.2%
Medical Equipment Industry Average Movement8.5%
Market Average Movement6.4%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market3.1%

Stabiele aandelenkoers: IVCR.Q's share price has been volatile over the past 3 months.

Volatiliteit in de loop van de tijd: IVCR.Q's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of US stocks.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
18852,800Geoff Purtillwww.invacare.com

Invacare Corporation Samenvatting

Hoe verhouden de winst en inkomsten van Invacare zich tot de beurswaarde?
IVCR.Q fundamentele statistieken
MarktkapitalisatieUS$512.81k
Inkomsten(TTM)-US$101.07m
Inkomsten(TTM)US$741.73m

0.0x

P/S-verhouding

0.0x

Koers/Winstverhouding

Is IVCR.Q overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
IVCR.Q resultatenrekening (TTM)
InkomstenUS$741.73m
Kosten van inkomstenUS$557.69m
BrutowinstUS$184.04m
Overige uitgavenUS$285.12m
Inkomsten-US$101.07m

Laatst gerapporteerde inkomsten

Dec 31, 2022

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)-2.66
Brutomarge24.81%
Nettowinstmarge-13.63%
Schuld/Eigen Vermogen Verhouding436.8%

Hoe presteerde IVCR.Q op de lange termijn?

Bekijk historische prestaties en vergelijking